ESMO Тargeted Anticancer Therapies Congress 2023 is a great platform for networking with colleagues, interacting with key opinion leaders, asking questions and debating on burning topics in the field of medical oncology, with a particular emphasis on those in early phase clinical development.
OCT Clinical will be represented at the event by Anna Yanaeva, Head of Development Manager. Book a meeting with OCT team to discuss your clinical trial options for your oncology study at ayanaeva@oct-clinicaltrials.com.
